Search results
Pharma companies less concerned after hearing from US on negotiated prices for Medicare
Reuters via Yahoo Finance Canada· 17 hours agoTop executives from Bristol Myers Squibb, Johnson & Johnson, AbbVie and AstraZeneca, which have five...
Breast cancer drug not recommended for NHS use after price talks break down
PA Media: UK News via Yahoo Canada News· 20 hours agoIt then paused its appraisal in December while commercial talks with pharmaceutical companies...
Issuers Pile Into Europe’s Primary Market Before Key Risk Events
Bloomberg· 22 hours agoHave a confidential tip for our reporters? Debt sales in Europe’s primary market were at a brisk...
School mums bond over shared cancer journey
BBC via Yahoo Canada News· 3 days agoIt added that without agreeing a price that represented a "cost-effective use of NHS resources" it could not recommend Enhertu, though said it was "open...
Bristol Myers surges 10%, its biggest increase since 2008, after boosting profit forecast
Business Insider via Yahoo Finance Canada· 3 days ago"We saw good growth in the first half [of the decade], and we expect good growth in the back half,"...
Bio developments
BioPharma-Reporter· 4 days agoAZ looks at Almac’s Flexyte platform for drug discovery AZ looks at Almac’s Flexyte platform for drug discovery 18-Jan-2010 By Gareth Macdonald UK drug major AstraZeneca will ...
Eaton Vance Worldwide Health Sciences Fund's Strategic Moves in Q2 2024: Spotlight on ...
GuruFocus.com via Yahoo Finance Canada· 5 days agoLilly and Co (NYSE:LLY), 7.54% in Novo Nordisk A/S (OCSE:NOVO B), 7% in UnitedHealth Group Inc...
AstraZeneca CEO: We're building '2 supply chains' to avoid impact of US-China tensions
Yahoo Finance· 5 days agoDespite growing tensions between the US and China, the global pharmaceutical industry continues to...
Ontario Ministry of Health Announces a Universal Public Program with Beyfortus® this RSV Season
CNW· 5 days agoThe Ontario Ministry of Health has announced a universal public program with Beyfortus® (nirsevimab) for all newborns and infants born in 2024 and through the 2024-2025 RSV season. This also ...
S&P 500 Fell By 2.3% But Don't Panic
Baystreet· 5 days agoYesterday’s selling pressure on above-average volume is a potential turning point for stock markets. Nasdaq’s (QQQ) 3.64% decline, due mostly to Nvidia (NVDA) and other technology mega-cap stocks ...
